Literature DB >> 19852759

A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling.

Christoph Kneip1, Bernd Schmidt, Michael Fleischhacker, Anke Seegebarth, Jörn Lewin, Nadja Flemming, Stefanie Seemann, Thomas Schlegel, Christian Witt, Volker Liebenberg, Dimo Dietrich.   

Abstract

DNA methylation is an important epigenetic mechanism involved in fundamental biological processes such as development, imprinting, and carcino-genesis. For these reasons, DNA methylation represents a valuable source for cancer biomarkers. Methods for the sensitive and specific detection of methylated DNA are a prerequisite for the implementation of DNA biomarkers into clinical routine when early detection based on the analysis of body fluids is desired. Here, a novel technique is presented for the detection of DNA methylation biomarkers, based on real-time PCR of bisulfite-treated template with enzymatic digestion of background DNA during amplification using the heat-stable enzyme Tsp509I. An assay for the lung cancer methylation biomarker BARHL2 was used to show clinical and analytical performance of the method in comparison with methylation-specific PCR technology. Both technologies showed comparable performance when analyzing technical DNA mixtures and bronchial lavage samples from 75 patients suspected of having lung cancer. The results demonstrate that the approach is useful for sensitive and specific detection of a few copies of methylated DNA in samples with a high background of unmethylated DNA, such as in clinical samples from body fluids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19852759     DOI: 10.2144/000113208

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  6 in total

1.  Restriction enzyme-mediated enhanced detection of circulating cell-free fetal DNA in maternal plasma.

Authors:  John A Tynan; Payam Mahboubi; Lesley L Cagasan; Dirk van den Boom; Mathias Ehrich; Paul Oeth
Journal:  J Mol Diagn       Date:  2011-05-06       Impact factor: 5.568

2.  A combined HM-PCR/SNuPE method for high sensitive detection of rare DNA methylation.

Authors:  Sascha Tierling; Matthias Schuster; Reimo Tetzner; Jörn Walter
Journal:  Epigenetics Chromatin       Date:  2010-06-02       Impact factor: 4.954

3.  SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates.

Authors:  Bernd Schmidt; Volker Liebenberg; Dimo Dietrich; Thomas Schlegel; Christoph Kneip; Anke Seegebarth; Nadja Flemming; Stefanie Seemann; Jürgen Distler; Jörn Lewin; Reimo Tetzner; Sabine Weickmann; Ulrike Wille; Triantafillos Liloglou; Olaide Raji; Martin Walshaw; Michael Fleischhacker; Christian Witt; John K Field
Journal:  BMC Cancer       Date:  2010-11-03       Impact factor: 4.430

4.  Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors.

Authors:  Katja U Schneider; Dimo Dietrich; Michael Fleischhacker; Gunda Leschber; Johannes Merk; Frank Schäper; Henk R Stapert; Erik R Vossenaar; Sabine Weickmann; Volker Liebenberg; Christoph Kneip; Anke Seegebarth; Fikret Erdogan; Gudrun Rappold; Bernd Schmidt
Journal:  BMC Cancer       Date:  2011-03-22       Impact factor: 4.430

5.  Improved PCR performance using template DNA from formalin-fixed and paraffin-embedded tissues by overcoming PCR inhibition.

Authors:  Dimo Dietrich; Barbara Uhl; Verena Sailer; Emily Eva Holmes; Maria Jung; Sebastian Meller; Glen Kristiansen
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

6.  Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.

Authors:  Dimo Dietrich; Maria Jung; Svenja Puetzer; Annette Leisse; Emily Eva Holmes; Sebastian Meller; Barbara Uhl; Philipp Schatz; Claudia Ivascu; Glen Kristiansen
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.